PL3875081T3 - Kompozycja farmaceutyczna zawierająca fosforan alkilo karbamoilo naftalenyloksy oktenoilo hydroksyamidu, winan lub ich kombinację, oraz sposób jej wytwarzania - Google Patents

Kompozycja farmaceutyczna zawierająca fosforan alkilo karbamoilo naftalenyloksy oktenoilo hydroksyamidu, winan lub ich kombinację, oraz sposób jej wytwarzania

Info

Publication number
PL3875081T3
PL3875081T3 PL19878899.4T PL19878899T PL3875081T3 PL 3875081 T3 PL3875081 T3 PL 3875081T3 PL 19878899 T PL19878899 T PL 19878899T PL 3875081 T3 PL3875081 T3 PL 3875081T3
Authority
PL
Poland
Prior art keywords
tartrate
phosphate
preparation
combination
pharmaceutical composition
Prior art date
Application number
PL19878899.4T
Other languages
English (en)
Inventor
Jae Pyoung Cho
Joong Myung Cho
Original Assignee
Crystalgenomics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crystalgenomics, Inc. filed Critical Crystalgenomics, Inc.
Publication of PL3875081T3 publication Critical patent/PL3875081T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19878899.4T 2018-10-29 2019-10-28 Kompozycja farmaceutyczna zawierająca fosforan alkilo karbamoilo naftalenyloksy oktenoilo hydroksyamidu, winan lub ich kombinację, oraz sposób jej wytwarzania PL3875081T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180129576A KR102678356B1 (ko) 2018-10-29 2018-10-29 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 인산염, 타르타르산염 또는 이들의 조합을 포함하는 약제학적 조성물 및 그 제조방법
PCT/KR2019/014234 WO2020091326A1 (ko) 2018-10-29 2019-10-28 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 인산염, 타르타르산염 또는 이들의 조합을 포함하는 약제학적 조성물 및 그 제조방법

Publications (1)

Publication Number Publication Date
PL3875081T3 true PL3875081T3 (pl) 2025-11-24

Family

ID=70464189

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19878899.4T PL3875081T3 (pl) 2018-10-29 2019-10-28 Kompozycja farmaceutyczna zawierająca fosforan alkilo karbamoilo naftalenyloksy oktenoilo hydroksyamidu, winan lub ich kombinację, oraz sposób jej wytwarzania

Country Status (12)

Country Link
US (1) US20210346321A1 (pl)
EP (1) EP3875081B1 (pl)
JP (1) JP7613744B2 (pl)
KR (1) KR102678356B1 (pl)
CN (1) CN112930177B (pl)
AU (1) AU2019369913B2 (pl)
BR (1) BR112021006286A2 (pl)
CA (1) CA3116574A1 (pl)
ES (1) ES3036263T3 (pl)
MX (1) MX2021003355A (pl)
PL (1) PL3875081T3 (pl)
WO (1) WO2020091326A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12553903B2 (en) * 2023-06-01 2026-02-17 Cg Pharmaceuticals, Inc Ivaltinostat combination therapy for treating pancreatic cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1212723A (fr) * 1958-01-09 1960-03-25 Rhone Poulenc Sa Nouveaux dérivés de la phénothiazine à chaîne carbamoylpipérazine et leur préparation
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
EP1686115A1 (de) * 2005-01-26 2006-08-02 Novartis AG Organische Säureadditionssalze von Valnemulin
KR100696139B1 (ko) * 2005-11-01 2007-03-20 한국화학연구원 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시 옥테노일 하이드록시아마이드 유도체 및그의 제조방법
KR100711944B1 (ko) 2005-11-01 2007-05-02 한국화학연구원 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시프로페닐 하이드록시벤즈아마이드 유도체,이의 제조방법 및 이를 유효성분으로 하는 항암제용 약학조성물
CL2007002499A1 (es) * 2006-08-30 2008-03-14 Phenomix Corp Sales citrato y tartrato de compuestos derivados de acido pirrolidinilaminoacetilpirrolidinboronico, inhibidores de dpp-iv; metodo de preparacion; forma solida; combinacion farmaceutica, util para el tratamiento de diabetes.
JP5277171B2 (ja) * 2006-11-03 2013-08-28 コリア リサーチ インスティテュート オブ ケミカル テクノロジーズ ヒストン脱アセチル化酵素阻害活性を有するナフタレニルオキシプロペニル誘導体およびこれを含む薬学組成物
KR100814092B1 (ko) * 2006-11-03 2008-03-14 한국화학연구원 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시 옥테노일 하이드록시아마이드 유도체, 이의제조방법 및 이를 유효성분으로 하는 항암제용 약학조성물
KR100814100B1 (ko) * 2006-11-03 2008-03-14 한국화학연구원 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시프로페닐 하이드록시벤즈아마이드 유도체,이의 제조방법 및 이를 유효성분으로 하는 항암제용 약학조성물
EP2065385A1 (en) * 2007-11-28 2009-06-03 Laboratorios SALVAT, S.A. Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
KR101388596B1 (ko) 2008-12-11 2014-04-24 대한민국 잠복성 hiv 감염 세포에서 hiv-1 프로바이러스를 재활성화시키는 히스톤 디아세틸라제 억제제
KR101978364B1 (ko) * 2017-06-15 2019-05-14 크리스탈지노믹스(주) 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법

Also Published As

Publication number Publication date
EP3875081B1 (en) 2025-07-09
KR102678356B1 (ko) 2024-06-26
EP3875081A1 (en) 2021-09-08
CN112930177B (zh) 2024-01-30
BR112021006286A2 (pt) 2021-07-06
ES3036263T3 (en) 2025-09-16
US20210346321A1 (en) 2021-11-11
MX2021003355A (es) 2021-08-11
CN112930177A (zh) 2021-06-08
AU2019369913B2 (en) 2024-10-31
CA3116574A1 (en) 2020-05-07
KR20200047996A (ko) 2020-05-08
EP3875081A4 (en) 2022-07-06
AU2019369913A1 (en) 2021-05-06
WO2020091326A1 (ko) 2020-05-07
EP3875081C0 (en) 2025-07-09
JP2022504055A (ja) 2022-01-13
JP7613744B2 (ja) 2025-01-15

Similar Documents

Publication Publication Date Title
IL289763A (en) Compounds, pharmaceutical compounds and methods for preparing compounds and their use
EP3539963A4 (en) NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE
ZA201906451B (en) 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same
SG11202111701XA (en) Coated drug compositions and methods of preparing the same
WO2016149401A3 (en) Piperazine carbamates and methods of making and using same
IL271807A (en) New compounds and their pharmaceutical preparations for the treatment of leprosy
PT3580208T (pt) Derivados de 2-(3-(1h-benzo[d]imidazol-1-il)propil)piperidin-3-ol e compostos relacionados como inibidores de prs para tratamento de, por exemplo, cancro
IL261444A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
IL276244A (en) A pharmaceutical preparation for the eyes, a method for its preparation and its application
ZA201901717B (en) Polymorphic form of kinase inhibitor compound, pharmaceutical composition containing same, and preparation method therefor and use thereof
EP3279207A4 (en) Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof
EP3176163A4 (en) Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient
WO2016077656A3 (en) Methods and compositions for inhibition of bromodomain and extraterminal proteins
SG11202110674XA (en) Compound, method and pharmaceutical composition for modulating expression of dux4
EP3647313A4 (en) SUBSTITUTED ARYLETHER COMPOUND, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND USE
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
EP3636281C0 (en) METHOD FOR TREATMENT OF DEPRESSION, AND PHARMACEUTICAL COMPOSITION
EP3138834A4 (en) Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
IL264511B1 (en) Aromatic heterocyclic nitrogen compounds, a method for their preparation, their pharmaceutical compositions and their use
HUE047537T2 (hu) Új heterociklusos vegyület, eljárás annak elõállítására, és az azt tartalmazó gyógyászati készítmény
EP3398608A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER OR CANCER METASTASES WITH PSTL1-PRTEIN AS AN ACTIVE SUBSTANCE
PL3811941T3 (pl) Kompozycja farmaceutyczna zawierająca ilaprazol i jego sól oraz sposób jej wytwarzania
EP3733670A4 (en) TETRAHYDROPYRROL COMPOUND, METHOD OF MANUFACTURE THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
HUE065421T2 (hu) Nazális adagolású rifampicint tartalmazó gyógyszerészeti készítmény demencia kezelésére
PL3898596T3 (pl) Związek farmaceutyczny, sposób jego wytwarzania i jego zastosowanie jako środek medyczny